ArticleBioMed research international2021

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer.

Zuyi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.